차입 증가 → 이자부담 → 수익성 악화
Critical부채가 +98.9% 늘며 이자보상배율이 105.8x에서 43.8x로 하락했다. ROE도 17.4%에서 9.6%로 낮아져 차입 부담이 수익성을 누르고 있다.
Evidence
BBIA — what's the grade? And what signals are flashing today?
Open the exact grade & valuation bands with Pro →Why these signals fired — only backtest-proven edge, told honestly
Not this one stock, but every strong-buy pick we actually published (Korea market). When this stock flashes the signal, it is treated by the same rule.(as of 2026-08-03)
Beat the market on 62.1% of picks (each pick vs its own day’s market average).
Entry is the latest close at publish time; next-day is the following close. “Market” is the equal-weighted average of every stock in the same market that day; delisted names are excluded from both. Fees, taxes and slippage are not included. An observed record over a short window, not a pre-registered backtest. Not investment advice.
Relative to 110 화학 peers · not investment advice
Split-adjusted annual DPS history and available grade axes
Paid 1 consecutive years · Raised 0 consecutive years · Yield 2.11% (based on 2025 payment of 150원)
Per-share amount adjusted for splits and capital reductions · Factual information, not investment advice.
Statistical manipulation-risk signal
부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.
Factual information, not investment advice.
Auditable observations with the original numeric evidence.
부채가 +98.9% 늘며 이자보상배율이 105.8x에서 43.8x로 하락했다. ROE도 17.4%에서 9.6%로 낮아져 차입 부담이 수익성을 누르고 있다.
Evidence
순운전자본이 +126.9% 팽창하며 현금이 묶이고 있다. 영업CF/순이익 비율이 -25%로 이익 대비 현금 회수가 부족하고, 유동비율도 7.90에서 6.90로 하락했다.
Evidence
Factual information, not investment advice.
Piotroski measures year-over-year financial improvement, not absolute quality.
Calculation note: F7(신주)은 equity/asset 유지로 근사
Already-stable companies may score lower when year-over-year improvement is limited.
Factual information, not investment advice.
Anomaly and structural signals observed in the financial statements.
현금전환주기(CCC) 3기 연속 확대 — 운전자본 경색·현금 회수 지연 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
영업이익률 악화 (12.4% → 7.1%, -5.3%p). 통계적 정황 신호이며 회계부정 단정이 아닙니다.
영업외손익 급변 (영업이익 대비 159% 규모 변동) — 일회성 손익 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.
Factual information, not investment advice.
화학
HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.
Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.
Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)
Factual information, not investment advice.
Metric changes under stated assumptions; not a forecast or investment advice.
Interest coverage limit at an operating margin of 0.2%
Interest expense coverage threshold
Suppliers disclosed by the company in its 2026-04-08 annual report.
BBIA's latest results and balance sheet. The bars track the last three periods.
A historical record from curated-guru 13F filings and DART 5%+ major-holding disclosures.
US 13F는 분기 공시이며 최대 45일 뒤 제출될 수 있습니다.
BBIA's latest filings on Korea's DART. Open a headline for a reference summary and the original.
Source: DART (Korea electronic disclosure)
Like these rules? Run them automatically.
Quantus turns rules like these into backtests and automated trading — same team, free to start.
Quantus Signal · live data · not investment advice · Privacy Policy